Mohammad-Reza Ardalan
*1 Chronic Kidney Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Abstract
We represent here a 30-year-old woman with cardiac leiomyosarcoma who developed thrombocytopenia and deep vein thrombosis a few days after the start of low molecular weight heparin. Thrombocytopenia improved after replacement of low molecular weight heparin with hirudine. We speculated that cardiac leiomyosarcoma is a predisposing factor for development of heparin induced thrombocytopenia.
Implication for health policy/practice/research/medical education:
It is possible that cardiac leiomyosarcoma is a predisposing factor for development of heparin induced thrombocytopenia.
Please cite this paper as: Ardalan MR. Confusing combination of thrombocytopenia and thrombosis after heparin therapy in a patient with cardiac leiomyosarcoma; a nephrologist viewpoint. J Nephropharmacol 2014; 3(2): 57-59.